Unexplained Variations in Patient Admissions: Part II

For my last article, I wrote about unexplained clinical variation as it pertains to surgical procedures. Today I continue exploring this theme.

For men with low-risk prostate cancer, randomized controlled trials have found that active treatment such as radiation or prostatectomy does not improve mortality rates as compared to an initial approach of observation. Thus, evidence-based guidelines conclude that observation is a reasonable initial strategy.

An analysis of a national database by Tyson and colleagues published this year included over 20,000 men over 66 years of age with low-risk prostate cancer and their nearly 1,900 treating urologists. Wide variation in the utilization of observation as a treatment strategy was found. Some urologists employed observation 5 to 30 percent of the time, while others used it as often as 60 to 70 percent of the time.

Considering the significant adverse effects of active treatment, such as impotence and urinary incontinence, and the lack of demonstrated mortality benefit of active treatment in low-risk patients, this degree of variation is concerning, from a cost perspective as well as a patient safety perspective.

Another area in which we can assess unexplained clinical variation is treatment of carotid artery stenosis.

When symptomatic, as stroke or transient ischemic attack (TIA), revascularization can be beneficial in terms of ensuring reduced subsequent incidence of stroke. When a patient is asymptomatic (that is, no history of stroke or TIA), treatment of carotid artery stenosis is more controversial. Evidence-based guidelines suggest that for asymptomatic patients, revascularization only should be considered in the presence of at least 70 percent stenosis, and even in this group, whether the procedure is beneficial or harmful is a close call.

With this as background, examination of the results of a study published this year by Shean and colleagues is relevant. They examined a database of over 57,000 carotid revascularization procedures, 85 percent carotid endarterectomy and 15 percent carotid artery stenting. For endarterectomy, the percentage of treated patients who were asymptomatic varied across regions from 46 to 69 percent, and for stenting from 29 to 51 percent.

Limiting the analysis to asymptomatic patients with stenosis of less than 70 percent, for whom revascularization is not of clear benefit, we find variation, but also disturbingly high utilization rates. The proportion of endarterectomies that were performed on this group varied threefold, from 3 to 9 percent, and for carotid stenting it varied more than sevenfold, from 3 percent to a stunning 22 percent.

Beyond the observed variation, it is difficult to account for a significant number of procedures being performed on patients for whom the risks almost certainly outweigh the potential benefits.

It is this sort of variation and questionable utilization that makes use of evidence-based guidelines so necessary. The twin concerns regarding cost and patient safety demand attention. At the same time, it is only through use of guidelines that are evidence-based and clinically valid that we can safely and appropriately intervene.

Substituting arbitrary criteria or target utilization rates is neither appropriate nor beneficial to patients. It is through the application of guidelines that are clinically sound and evidence-based, such as those produced by MCG, that we can address both the cost and the safety aspects of unexplained clinical variation.

Links to cited studies:

Shean KE, et al. Regional variation in patient selection and treatment for carotid artery disease in the Vascular Quality Initiative. Journal of Vascular Surgery 2017;66(1):112-121. DOI: 10.1016/j.jvs.2017.01.023.

Tyson MD, et al. Urologist-level correlation in the use of observation for low- and high-risk prostate cancer. JAMA Surgery 2017;152(1):27-34. DOI: 10.1001/jamasurg.2016.2907.

Print Friendly, PDF & Email
Facebook
Twitter
LinkedIn

Bill Rifkin MD, FHM, FACP

Dr. Bill Rifkin is the associate vice president and managing editor of MCG Health. Dr. Rifkin oversees all research and content published by MCG Health that is focused on acute inpatient care. His expertise expands to hospital medicine and clinical care, where he has published multiple research documents.

Related Stories

How to Report New Code Category W44

How to Report New Code Category W44

One of the goals of medical coding is documenting encounter notes to the highest degree of specificity. ICD-10-CM had some existing codes for documenting foreign

Read More

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

Leveraging the CERT: A New Coding and Billing Risk Assessment Plan

Leveraging the CERT: A New Coding and Billing Risk Assessment Plan

Frank Cohen shows you how to leverage the Comprehensive Error Rate Testing Program (CERT) to create your own internal coding and billing risk assessment plan, including granular identification of risk areas and prioritizing audit tasks and functions resulting in decreased claim submission errors, reduced risk of audit-related damages, and a smoother, more efficient reimbursement process from Medicare.

April 9, 2024
2024 Observation Services Billing: How to Get It Right

2024 Observation Services Billing: How to Get It Right

Dr. Ronald Hirsch presents an essential “A to Z” review of Observation, including proper use for Medicare, Medicare Advantage, and commercial payers. He addresses the correct use of Observation in medical patients and surgical patients, and how to deal with the billing of unnecessary Observation services, professional fee billing, and more.

March 21, 2024
Top-10 Compliance Risk Areas for Hospitals & Physicians in 2024: Get Ahead of Federal Audit Targets

Top-10 Compliance Risk Areas for Hospitals & Physicians in 2024: Get Ahead of Federal Audit Targets

Explore the top-10 federal audit targets for 2024 in our webcast, “Top-10 Compliance Risk Areas for Hospitals & Physicians in 2024: Get Ahead of Federal Audit Targets,” featuring Certified Compliance Officer Michael G. Calahan, PA, MBA. Gain insights and best practices to proactively address risks, enhance compliance, and ensure financial well-being for your healthcare facility or practice. Join us for a comprehensive guide to successfully navigating the federal audit landscape.

February 22, 2024
Mastering Healthcare Refunds: Navigating Compliance with Confidence

Mastering Healthcare Refunds: Navigating Compliance with Confidence

Join healthcare attorney David Glaser, as he debunks refund myths, clarifies compliance essentials, and empowers healthcare professionals to safeguard facility finances. Uncover the secrets behind when to refund and why it matters. Don’t miss this crucial insight into strategic refund management.

February 29, 2024
2024 ICD-10-CM/PCS Coding Clinic Update Webcast Series

2024 ICD-10-CM/PCS Coding Clinic Update Webcast Series

HIM coding expert, Kay Piper, RHIA, CDIP, CCS, reviews the guidance and updates coders and CDIs on important information in each of the AHA’s 2024 ICD-10-CM/PCS Quarterly Coding Clinics in easy-to-access on-demand webcasts, available shortly after each official publication.

April 15, 2024

Trending News

SPRING INTO SAVINGS! Get 21% OFF during our exclusive two-day sale starting 3/21/2024. Use SPRING24 at checkout to claim this offer. Click here to learn more →